Insider Buying: Maximus (NYSE:MMS) CFO Buys $75,620.00 in Stock

Maximus, Inc. (NYSE:MMS) CFO David Mutryn purchased 1,000 shares of the business’s stock in a transaction on Monday, February 9th. The shares were acquired at an average price of $75.62 per share, for a total transaction of $75,620.00. Following the completion of the purchase, the chief financial officer directly owned 40,037 shares of the company’s stock, valued at approximately $3,027,597.94. This trade represents a 2.56% increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink.

Maximus Price Performance

Maximus stock opened at $75.68 on Thursday. The company has a quick ratio of 2.34, a current ratio of 2.34 and a debt-to-equity ratio of 0.88. Maximus, Inc. has a 52-week low of $63.77 and a 52-week high of $100.00. The firm has a market cap of $4.13 billion, a PE ratio of 11.52 and a beta of 0.57. The company’s 50 day moving average is $89.50 and its two-hundred day moving average is $86.55.

Maximus (NYSE:MMS) last posted its quarterly earnings data on Thursday, February 5th. The health services provider reported $1.85 earnings per share for the quarter, topping analysts’ consensus estimates of $1.84 by $0.01. The business had revenue of $1.35 billion for the quarter, compared to analyst estimates of $1.37 billion. Maximus had a return on equity of 25.30% and a net margin of 6.92%.The company’s revenue was down 4.1% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.61 earnings per share. Maximus has set its FY 2026 guidance at 8.050-8.350 EPS. On average, research analysts expect that Maximus, Inc. will post 6.15 EPS for the current fiscal year.

Maximus Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Monday, March 2nd. Stockholders of record on Friday, February 13th will be given a dividend of $0.33 per share. This is a boost from Maximus’s previous quarterly dividend of $0.30. This represents a $1.32 dividend on an annualized basis and a dividend yield of 1.7%. The ex-dividend date of this dividend is Friday, February 13th. Maximus’s dividend payout ratio is presently 18.26%.

Analyst Upgrades and Downgrades

Several research analysts have commented on the stock. Wall Street Zen cut shares of Maximus from a “buy” rating to a “hold” rating in a report on Saturday, February 7th. Zacks Research upgraded shares of Maximus from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, December 30th. Finally, Weiss Ratings reissued a “buy (b-)” rating on shares of Maximus in a report on Monday, December 29th. One research analyst has rated the stock with a Strong Buy rating and one has issued a Buy rating to the company’s stock. According to data from MarketBeat, Maximus presently has a consensus rating of “Strong Buy”.

Institutional Inflows and Outflows

A number of hedge funds have recently modified their holdings of MMS. Picton Mahoney Asset Management lifted its position in Maximus by 73,738.5% in the fourth quarter. Picton Mahoney Asset Management now owns 9,599 shares of the health services provider’s stock valued at $829,000 after acquiring an additional 9,586 shares during the last quarter. Empowered Funds LLC increased its position in shares of Maximus by 266.4% during the fourth quarter. Empowered Funds LLC now owns 9,544 shares of the health services provider’s stock worth $824,000 after purchasing an additional 6,939 shares in the last quarter. LPL Financial LLC increased its position in shares of Maximus by 8.3% during the fourth quarter. LPL Financial LLC now owns 10,588 shares of the health services provider’s stock worth $914,000 after purchasing an additional 809 shares in the last quarter. O Shaughnessy Asset Management LLC lifted its holdings in shares of Maximus by 10.7% in the 4th quarter. O Shaughnessy Asset Management LLC now owns 11,750 shares of the health services provider’s stock valued at $1,014,000 after purchasing an additional 1,138 shares during the last quarter. Finally, Palladiem LLC acquired a new stake in shares of Maximus in the 4th quarter valued at about $85,000. 97.21% of the stock is owned by hedge funds and other institutional investors.

About Maximus

Maximus, Inc (NYSE: MMS) is a global provider of government services focused on delivering health and human services programs. The company partners with federal, state, and local agencies to administer and manage programs that support individuals and families across various stages of life. Key service areas include eligibility determination and enrollment services for Medicaid, Medicare, Children’s Health Insurance Program (CHIP) and other public assistance programs, as well as call center operations, case management and program integrity solutions.